X

Xilio Therapeutics Inc
NASDAQ:XLO

Watchlist Manager
Xilio Therapeutics Inc
NASDAQ:XLO
Watchlist
Price: 0.6653 USD 0.47%
Market Cap: 34.9m USD

Intrinsic Value

The intrinsic value of one XLO stock under the Base Case scenario is 1.9771 USD. Compared to the current market price of 0.6653 USD, Xilio Therapeutics Inc is Undervalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XLO Intrinsic Value
1.9771 USD
Undervaluation 66%
Intrinsic Value
Price
X
Worst Case
Base Case
Best Case

Valuation History
Xilio Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about XLO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is XLO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Xilio Therapeutics Inc.

Explain Valuation
Compare XLO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XLO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xilio Therapeutics Inc

Current Assets 124.1m
Cash & Short-Term Investments 103.8m
Receivables 17.5m
Other Current Assets 2.8m
Non-Current Assets 9.6m
PP&E 7.8m
Other Non-Current Assets 1.8m
Current Liabilities 56.4m
Accounts Payable 2.3m
Accrued Liabilities 10.3m
Other Current Liabilities 43.8m
Non-Current Liabilities 85.4m
Other Non-Current Liabilities 85.4m
Efficiency

Free Cash Flow Analysis
Xilio Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Xilio Therapeutics Inc

Revenue
31.8m USD
Operating Expenses
-75.6m USD
Operating Income
-43.8m USD
Other Expenses
-14.7m USD
Net Income
-58.5m USD
Fundamental Scores

XLO Profitability Score
Profitability Due Diligence

Xilio Therapeutics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
19/100
Profitability
Score

Xilio Therapeutics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

XLO Solvency Score
Solvency Due Diligence

Xilio Therapeutics Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
38/100
Solvency
Score

Xilio Therapeutics Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XLO Price Targets Summary
Xilio Therapeutics Inc

Wall Street analysts forecast XLO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XLO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
204% Upside
Average
Price Target
2.04 USD
207% Upside
Highest
Price Target
2.1 USD
216% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Xilio Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for XLO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

XLO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one XLO stock?

The intrinsic value of one XLO stock under the Base Case scenario is 1.9771 USD.

Is XLO stock undervalued or overvalued?

Compared to the current market price of 0.6653 USD, Xilio Therapeutics Inc is Undervalued by 66%.

Back to Top